iShares Neuroscience and Healthcare ETF
IBRN
4 hedge funds and large institutions have $2.67M invested in iShares Neuroscience and Healthcare ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8.29% less ownership
Funds ownership: 83.75% → 75.46% (-8.3%)
17% less capital invested
Capital invested by funds: $3.21M → $2.67M (-$544K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$184K |
| 2 |
TFF
The Family Firm
Bethesda,
Maryland
|
+$2.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$480K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$35.9K |
IBRN Hedge Fund Activity: Q2 2024 in Review
4 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q2 2024, worth a combined $2.67M — down 17% from $3.21M a quarter earlier.
Fund positioning in IBRN was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Flow Traders U.S., adding an estimated $184K. The largest seller was Jane Street, exiting entirely with an estimated $480K sold.
- 4 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $2.67M of iShares Neuroscience and Healthcare ETF stock for Q2 2024, down 17% quarter-over-quarter.
- 1 fund opened new iShares Neuroscience and Healthcare ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q2 2024 was Flow Traders U.S., an estimated $184K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q2 2024 was Jane Street, an estimated $480K sold.
Based on aggregated 13F filings for Q2 2024.